Sort   by:  
 Page size 
ProteomicsiTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics
Mertins P, Udeshi ND, Clauser KR, Mani DR, Patel J, Ong, SE, Jaffe JD, Carr SA. Mol Cell Proteomics 2012, mcp.M111.014423. doi:10.1074/mcp.M111.014423. Tranche_hash:5cHw5Rj36vYNshNpy8k4nojtPyW27N/FHcImna3+zw4QV6KIlLOg3i6zesWBdWkEX608MEgdxWuVyKvvdOgB9BAanesAAAAAAACEzw==
2013-11-20 | MSV000078495 | MassIVE
ProteomicsIntegrated proteomic analysis of post-translational modifications by serial enrichment.
Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, Burgess MW, Gillette MA, Jaffe JD, Carr SA. Nat Methods 2013, 10, 634-7. doi: 10.1038/nmeth.2518.
2013-12-10 | MSV000078509 | MassIVE
ProteomicsReduced-representation Phosphosignatures Measured by Quantitative Targeted MS
Abelin JG, Patel J, Lu X, Feeney CM, Fagbami L, Creech AL, Hu R, Lam D, Davison D, Pino L, Qiao JW, Kuhn E, Officer A,Li J, Abbatiello S, Subramanian A, Sidman R, Snyder E, Carr SA, Jaffe JD. Mol Cell Proteomics, 2016. Profiling posttranslational modifications represents an alternative dimension to ...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2016-02-23 | MSV000079524 | MassIVE
ProteomicsInteraction studies of risk proteins in human induced neurons reveal convergent biology and novel mechanisms underlying autism spectrum disorders
Pintacuda G, Hsu YH, Tsafou K, Li KW, Martin JM, Riseman J, Biagini JC, Ching JKT, Gonzalez-Lozano MA, Egri SB, Jaffe JD, Smit AB, Fornelos N, Eggan KC, Lage K. 2022. Sequencing studies of autism spectrum disorders (ASDs) have identified numerous risk genes with enriched expression in the human brai...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2022-05-09 | MSV000089445 | MassIVE
ProteomicsEpigenetic Silencing by SETDB1 Suppresses Tumor-cell Intrinsic Immunogenicity
Griffin GK, Wu J, Iracheta-Vellve A, Patti JC, Hsu J, Davis T, Dele-Oni D, Du PP, Halawi A, Ishizuka JJ, Kim S, Klaeger S, Knudsen NH, Miller BC, Nguyen T, Olander K, Papanastasiou M, Rachimi S, Robitschek EJ, Schneider EM, Yeary M, Zimmer M, Jaffe JD, Carr SA, Doench JG, Haining WN, Yates KB, Mangu...
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2020-12-11 | MSV000086580 | MassIVE
ProteomicsNatural genetic variation on proteome level in Caenorhabditis elegans
Natural genetic variation is the raw material of evolution and influences disease development and progression. To analyze the effect of the genetic background on protein expression in the nematode C. elegans (Caenorhabditis elegans), the two genetically highly divergent wild-type strains N2 (Bristol...
ORGANISM(S): Caenorhabditis elegans 
2016-03-11 | PXD002010 | Pride
C. elegans Cb4856 N2 Silac Aging 
ProteomicsQuantifying homologous proteins and proteoforms
Many proteoforms - arising from alternative splicing, post-translational modifications (PTMs), or paralogous genes - have distinct biological functions, such as histone PTM proteoforms. However, their quantification by existing bottom-up mass-spectrometry (MS) methods is undermined by peptide-specif...
ORGANISM(S): Saccharomycetales (ncbitaxon:4892) Homo Sapiens (ncbitaxon:9606) 
2017-12-22 | MSV000081857 | MassIVE
GenomicsPCGP Histone-Capture bams - samples
DATA FILES FOR Histone Capture bams
EGAD00001000657 | EGA
GenomicsThe landscape of somatic mutations in epigenetic regulators across 1000 pediatric cancer genomes
To define the frequency and pattern of somatic mutations in epigenetic regulators in pediatric cancer, we sequenced 633 genes, encoding the majority of proteins involved in patterning the epigenome, in 1000 pediatric tumors spanning 21 different cancer subtypes. This analysis establishes an epigenet...
EGAS00001000449 | EGA
UnknownCombination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma.
Not available
S-EPMC11192235 | biostudies-literature
Sort   by:  
 Page size